The use of guselkumab in psoriatic arthritis: evidence from real clinical practice
Psoriatic arthritis (PsA) is a chronic inflammatory disease of the joints, spine and enthesis from the group of spondyloarthritis that develops in patients with psoriasis. Guselkumab is a biologic disease-modifying antirheumatic drug, an inhibitor of interleukin 23, which has been shown to be effect...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Russo |
| Vydáno: |
IMA-PRESS LLC
2021-12-01
|
| Edice: | Современная ревматология |
| Témata: | |
| On-line přístup: | https://mrj.ima-press.net/mrj/article/view/1234 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|